Status:

UNKNOWN

Physician Acceptance of the NeuTrace System for Cardiac Electroanatomic Mapping

Lead Sponsor:

NeuTrace, Inc.

Conditions:

Arrhythmias, Cardiac

Atrial Fibrillation

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The trial is a prospective, non-randomized, single-arm feasibility trial to evaluate physician acceptance of the NeuTrace System v1.0 for cardiac electroanatomic mapping.

Detailed Description

Arrhythmias, or abnormal heart rhythms, are a major cause of morbidity and mortality worldwide. In patients with arrhythmias, electrophysiology (EP) studies are often performed to assess the electrica...

Eligibility Criteria

Inclusion

  • Patient with standard indications for an electrophysiology study and/or catheter ablation per European Heart Rhythm Association/Heart Rhythm Society) guidelines and/or judgement of the investigator
  • Age 18 to 80
  • Signed Informed Consent Form

Exclusion

  • Any cardiac surgery, myocardial infarction, percutaneous coronary intervention/percutaneous transluminal coronary angioplasty, or coronary artery stenting which occurred during the 90-day interval preceding the date that participant signed the Informed Consent Form
  • Unstable angina
  • NHYA class III or IV congestive heart failure and/or known left ventricular ejection fraction less than 45%
  • Thrombocytosis, thrombocytopenia
  • Contraindication to anticoagulation therapy
  • Active systemic infection
  • Cryoglobulinemia
  • Known reversible causes of arrhythmia
  • Any cerebral ischemic event (stroke or transient ischemic attacks) which occurred during the 180-day interval preceding the date the participant signed the Informed Consent Form, or any known unresolved complications from the previous stroke/transient ischemic attack
  • Pregnancy
  • Unwilling or unable to comply fully with study procedures

Key Trial Info

Start Date :

June 7 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 7 2024

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT05214170

Start Date

June 7 2021

End Date

June 7 2024

Last Update

April 7 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vilnius University Hospital Santaros Klinikos

Vilnius, Lithuania, 08661